tariquidar has been researched along with vexibinol in 1 studies
| Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (vexibinol) | Trials (vexibinol) | Recent Studies (post-2010) (vexibinol) |
|---|---|---|---|---|---|
| 210 | 16 | 138 | 47 | 0 | 30 |
| Protein | Taxonomy | tariquidar (IC50) | vexibinol (IC50) |
|---|---|---|---|
| Voltage-dependent T-type calcium channel subunit alpha-1G | Homo sapiens (human) | 1 | |
| Voltage-dependent T-type calcium channel subunit alpha-1H | Homo sapiens (human) | 1 | |
| Sodium/glucose cotransporter 2 | Homo sapiens (human) | 4.1 | |
| Beta-secretase 1 | Homo sapiens (human) | 5.2 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 2.205 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YT; Huang, YH; Hung, TH; Li, YQ; Wu, CP; Wu, YS | 1 |
1 other study(ies) available for tariquidar and vexibinol
| Article | Year |
|---|---|
Sophoraflavanone G Resensitizes ABCG2-Overexpressing Multidrug-Resistant Non-Small-Cell Lung Cancer Cells to Chemotherapeutic Drugs.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavanones; Humans; Molecular Docking Simulation; Neoplasm Proteins | 2021 |